DGAP-News: Balda AG: preliminary 2013 / 2014 results and forecast – Interim-stage concluded, personnel changes to Management Board


DGAP-News: Balda AG / Key word(s): Final Results/Change of Personnel

Balda AG: preliminary 2013 / 2014 results and forecast – Interim-stage

concluded, personnel changes to Management Board

28.08.2014 / 10:30


– Revenue of EUR 70.5 million within targeted range

– EBITDA margin of around 5.6 % and EBITDA of around EUR 4.0 million before

extraordinary items also according to expectations

– Group consolidation and transformation largely concluded

– Supervisory Board meeting confirms Oliver Oechsle as Management Board

member for two more years

– Service contract of Dr. Dieter Brenken ends as planned

Bad Oeynhausen, 27 August 2014 – Balda AG presents the preliminary results

for the 2013 / 2014 financial year. Accordingly, the company has reached

the objectives that it had set for itself, achieving the lower end of its

targeted range: consolidated revenue stood at EUR 70.5 million, compared

with EUR 59.9 million in the prior-year period, reflecting a 17.7 % growth.

This increase is predominately attributable to the full consolidation for

the first time of the US companies acquired in 2012.

The company generated earnings before interest, tax, depreciation and

amortization (EBITDA) of around EUR 4.0 million before extraordinary items,

and an EBITDA margin of around 5.6 % as forecasted. After taking into

account depreciation, amortization and extraordinary items, earnings before

interest and tax (EBIT) stood at around EUR -4.6 million. For the current

financial year of 2014 / 2015 Balda aims at an increase to revenues of EUR

73 to 78 million, provided that currencies will not develop adversely.

Further a positive EBIT is expected with a low one-digit EBIT-margin.

“We restructured the whole Group last year, and fully integrated our US

sites. We are very content because Balda AG is now perceived on the market

as a comprehensive plastics specialist. Our results also show that we are

on the right track,”, is how Oliver Oechsle, Management Board member of

Balda AG, comments on developments during the past financial year, before

adding: “We have prepared ourselves for the future, and our clear objective

is to grow internationally now. Our high level of cash reserves also gives

us the financial strength to realize a large acquisition.”

In addition, the Supervisory Board has taken decisions about the company’s

future management, and ended the interim management arrangement. The

appointment of Oliver Oechsle as a Management Board member was extended for

a two-year period. Dr. Dieter Brenken, who has been active as Chief

Financial Officer to date, is to leave the company at the end of October.

The interim manager was appointed for this period to oversee and implement

Balda’s transformation and consolidation process. Dr. Brenken has made a

significant contribution to the reorientation of Balda’s international

activities and commercial management. The company has simplified its

structures during the past financial year, and reorganized its segments

according to regions.

“We are sorry that Dr. Brenken is leaving us, and we would like to thank

him very much for his commitment in having helped restore Balda AG to a

condition of fitness for the future. Balda was able to launch and

successfully implement the necessary transformation processes over the past

year due to his enormous experience,” commented Dr. Thomas van Aubel,

Supervisory Board Chairman of Balda AG, before adding: “Also on behalf of

all of our employees, the Supervisory and Management boards of Balda AG

would like to wish Dr. Brenken all the best for the future, both

professionally and personally.”

The 2013 / 2014 annual report of Balda AG will be published on 10 October

2014, when it will be available for downloading from the company’s website

at www.balda-group.com/de.


Daniela Münster

Deekeling Arndt Advisors

Phone: +49 (0) 69 97098 511

Mail: daniela.muenster@deekeling-arndt.de

About Balda

Balda is a provider of first-class solutions in plastics for demanding,

high-quality applications in the fields of healthcare, lifestyle,

automotive and consumer electronics industries. Balda has operating

divisions in Europe and America and maintains state-of-the-art production

facilities at its headquarter in Bad Oeynhausen, Germany as well as in the

USA. The success of Balda, which employs around 700 people, is based on the

deployment of leading-edge, cost-effective technologies, coupled with the

trust-based and close collaboration with customers. The Balda AG share

(ISIN: DE0005215107) is listed on the SDAX segment of Deutsche Börse.



28.08.2014 Dissemination of a Corporate News, transmitted by DGAP – a

service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English

Company: Balda AG

Bergkirchener Str. 228

32549 Bad Oeynhausen


Phone: +49 (0) 57 34 / 9 22-0

Fax: +49 (0) 57 34 / 9 22-2604

E-mail: info@Balda.de

Internet: www.balda.de

ISIN: DE0005215107

WKN: 521510

Listed: Regulierter Markt in Frankfurt (Prime Standard);

Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,

München, Stuttgart

End of News DGAP News-Service


284362 28.08.2014